11. Depression screening and use of supportive care services in prostate cancer. Issue 28 (1st October 2022) Authors: Wong, Risa Liang; Cheng, Heather H.; Fann, Jesse R.; Hnida, James; Chakoian, Marty; Jannat, Samia; Schenker, Yael; Yu, Evan Y.; Gore, John L. Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. (2021) Authors: Taza, Fadi; Holler, Albert E.; Fu, Wei; Wang, Hao; Adra, Nabil; Albany, Costantine; Ashkar, Ryan; Cheng, Heather H.; Sokolova, Alexandra O.; Agarwal, Neeraj; Kessel, Adam; Bryce, Alan; Nafissi, Nellie; Barata, Pedro; Sartor, A. Oliver; Bastos, Diogo; Smaletz, Oren; Berchuck, Jacob E.; Taplin, Mar... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer. Issue 3 (16th November 2022) Authors: Su, Christopher T.; Nizialek, Emily; Berchuck, Jacob E.; Vlachostergios, Panagiotis J.; Ashkar, Ryan; Sokolova, Alexandra; Barata, Pedro C.; Aggarwal, Rahul R.; McKay, Rana R.; Agarwal, Neeraj; McClure, Heather M.; Nafissi, Nellie; Bryce, Alan H.; Sartor, Oliver; Sayegh, Nicolas; Cheng, Heather H... Journal: Prostate Issue: Volume 83:Issue 3(2023) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. Issue 16 (13th September 2021) Authors: Sokolova, Alexandra O.; Marshall, Catherine H.; Lozano, Rebeca; Gulati, Roman; Ledet, Elisa M.; De Sarkar, Navonil; Grivas, Petros; Higano, Celestia S.; Montgomery, Bruce; Nelson, Peter S.; Olmos, David; Sokolov, Vadim; Schweizer, Michael T.; Yezefski, Todd A.; Yu, Evan Y.; Paller, Channing J.; S... Journal: Prostate Issue: Volume 81:Issue 16(2021) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Germline genetics of prostate cancer. (3rd June 2022) Authors: Khan, Hiba M.; Cheng, Heather H. Journal: Prostate Issue: Volume 82(2022)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. MP56-06 ASSOCIATIONS BETWEEN SKELETAL MUSCLE GAUGE AND SURVIVAL FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER: A NOVEL ASSESSMENT OF MUSCLE MASS AND QUALITY. (May 2022) Authors: Noonavath, Meghana; Mun, Kevin; Marquardt, J. Peter; Fintelmann, Florian J.; O'Malley, Ryan; Holt, Sarah K.; Dwyer, Erin; Maldonado, Reno; Diamantopoulos, Leonidas; Makrakis, Dimitrios; Laidlaw, Grace; Schade, George R.; Lin, Dan W.; Wright, Jonathan L.; Gore, John L.; Nyame, Yaw; Grivas, Petros;... Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. Issue 3 (March 2022) Authors: Smith, Matthew R; Scher, Howard I; Sandhu, Shahneen; Efstathiou, Eleni; Lara, Primo N; Yu, Evan Y; George, Daniel J; Chi, Kim N; Saad, Fred; Ståhl, Olof; Olmos, David; Danila, Daniel C; Mason, Gary E; Espina, Byron M; Zhao, Xin; Urtishak, Karen A; Francis, Peter; Lopez-Gitlitz, Angela; Fizazi, Ka... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. (8th December 2013) Authors: Lee, Franklin C.; Harris, William; Cheng, Heather H.; Shenoi, Jaideep; Zhao, Song; Wang, Junfeng; Champion, Thomas; Izard, Jason; Gore, John L.; Porter, Michael; Yu, Evan Y.; Wright, Jonathan L. Other Names: Djordjevic Miroslav L. Academic Editor. Journal: Advances in urology Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Undetectable prostate‐specific antigen after short‐course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis‐free survival and prostate cancer‐specific survival. Issue 14 (10th July 2018) Authors: Lim, Daniel M.; Gulati, Roman; Aleshin‐Guendel, Serge; Gawne, Agnes; Wingate, Jonathan T.; Cheng, Heather H.; Etzioni, Ruth; Yu, Evan Y. Journal: Prostate Issue: Volume 78:Issue 14(2018) Page Start: 1077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗